Cite
HARVARD Citation
Leibowitz-Amit, R. et al. (2016). Changes in plasma biomarkers following treatment with cabozantinib in metastatic castration-resistant prostate cancer: a post hoc analysis of an extension cohort of a phase II trial. Journal of translational medicine. 14 (1), pp. 1-8. [Online].